All Q1 FY27 results →
O

Orkla India

Q1 FY27Food Products

Orkla India Q1 FY27 earnings call: Revenue & Margins

Q1 FY27 earnings call: what management said on revenue, margins and capex.

Price₹567
Market cap₹7.6K Cr
P/E24.8
Updated25 Aug 2026
Read3 min read

What the Q1 FY27 call signalled

1 of 3 strong

RevenueModerate growth
MarginMargins steady
CapexCapex planned

The short version

Orkla India aims for sustained double-digit growth in sales and revenue, focusing on volume expansion. Orkla India aims to deliver double-digit revenue growth as a core ambition.

From Orkla India's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.

Revenue & Sales Performance

Moderate growth
  • Orkla India aims for sustained double-digit growth in sales and revenue, focusing on volume expansion.
  • Volume growth target is around 5-6%, seen as substantial given market dynamics.
  • Growth is expected to be driven by multiple engines: spices, convenience foods, digital commerce, and international business.
  • Investment priorities include nutrition-enriched products, innovation (23 innovations in the recent quarter), and digital commerce acceleration (38.1% growth in Q1 digital sales).
  • Distribution restructuring in Kerala aims to strengthen market presence and regain market share.
  • The company is open to increased advertising and sales promotion spending to accelerate growth.

2 more points from Orkla India's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Orkla India said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Capex planned
  • Orkla India is investing significantly behind growth, focusing on driving volume growth as the single most important driver going forward.
  • They are open to increased spending behind Advertising & Sales Promotion (A&SP) to support growth.
  • Project Bolt: Strategic investment to build digital commerce capabilities across people, technology, analytics, and digital-native innovations, aiming to accelerate innovation and growth through online channels.
  • Investment in distribution restructuring, especially in Kerala, to strengthen route-to-market and create a scalable platform for future growth.
  • Innovation pipeline actively accelerated, with 23 new innovations launched in the recent quarter, focusing on nutritionally-enriched and consumer trend-aligned products.

2 more points from Orkla India's call on capex

Create a free account to keep reading this call

Top-ranked in Food Products

Ranked on what management guided this quarter

Guidance-ranked
1Milky Mist Dairy
Rev 1Mar 1
Rev 1Mar 1
3
Rev 1Mar 1
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Orkla India said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Orkla India said on order book & pipeline — free account, 30 seconds.

Orkla India — Quarterly revenue & net profit

Revenue Net profit
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Q1 FY27 figures are not in this chart yet. Latest shown: Mar 2026 (Q4 FY26). The Q1 FY27 numbers from the filing are in the analysis on this page.

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹626 Cr, net profit ₹73 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Food Products this season

  • Wardwizard Foods (Q1 FY27)

    Revenue for Q1 FY27 (June 2026 quarter) is ₹17.03 Cr, up from ₹13.20 Cr in Q1 FY26, reflecting a strong year-on-year growth. Key investor presentation takeaways

  • Chemkart India (Q1 FY27)

    Revenue from operations for Apr–Jun FY27 reported at INR 99.60 crore (INR 9,960.22 lakhs). Key investor presentation takeaways from Chemkart India Ltd's Q1 FY27

  • Sheetal Cool (Q1 FY27)

    Revenue from Operations for FY26: ₹366.0 Crores, up 13.9% YoY from ₹321.3 Crores in FY25 (Page 29, 5). Key investor presentation takeaways from Sheetal Cool Pro

  • Mukka Proteins (Q1 FY27)

    Q1 FY27 Revenue from Operations: ₹489.7 crore . Key concall takeaways from Mukka Proteins Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Orkla India and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Orkla India Q1 FY27 results?

Orkla India aims for sustained double-digit growth in sales and revenue, focusing on volume expansion. Orkla India aims to deliver double-digit revenue growth as a core ambition.

What is Orkla India share price analysis?

Orkla India currently shows a below-average growth signal. The stock trades at a P/E of 24.8 with a market cap of ₹7,565 Cr. Investors should review the full earnings analysis for detailed insights.

Is Orkla India planning capital expenditure?

Orkla India is investing significantly behind growth, focusing on driving volume growth as the single most important driver going forward.

Keep Orkla India on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.